bpc-157 oral administration for gut issues Multifunctionality and Possible Medical Application of the BPC 157 Peptide—Literature and Patent Review BPC-157 Explained: Benefits, Safety &

Abdominal fat increases intra-abdominal pressure, forcing stomach contents upward against the lower esophageal sphincter

Absolute contraindications include: Active malignancy of any kind (GH and IGF-1 are growth-promoting signals) Active diabetic retinopathy (IGF-1 may worsen retinal vascularity) Pregnancy or breastfeeding Known hypersensitivity to any component of the formulation Pituitary tumours or untreated hypothalamic disease Relative contraindications requiring careful evaluation include pre-existing insulin resistance, type 2 diabetes, uncontrolled cardiovascular disease, and sleep apnoea (GH elevation can worsen upper airway tone in susceptible individuals)

Current research does not show that BPC-157 directly causes weight loss

For context, the fat-mass reductions reported in Billon 2024 roughly 25-30% in diet-induced obese mice over 28 days without exercise are large for a preclinical metabolic agent and explain why the "exercise mimetic" label stuck

There isnt a better form of BPC-157 only a better match for the situation